JohnLBarstisMD

PubMed

• 26 citations
  Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
  Nu T. Lu, Jeffrey Raizer, Erwin P. Gabor, Natalie M. Liu, James Q. Vu, Dennis J. Slamon, John Barstis> ;Journal for Immunotherapy of Cancer. 2015 Sep 15
• 3 citations
  Breast-conservation treatment outcomes: a community hospital's experience.
  Barbara D. Florentine, Neal Kaushal, Melissa R. Puig, Nayibe Sarda, Greg Senofsky, Brian T. Cooper, Alexander C. Black, Robert Zimmerman, John Barstis> ;The Breast Journal. 2009 Jan 1
• 8 citations
  Cost savings associated with the use of fine-needle aspiration biopsy (FNAB) for the diagnosis of palpable masses in a community hospital-based FNAB clinic
  Barbara D. Florentine, Barry Staymates, Munif Rabadi, Nayibe Sarda, John Barstis, Alexander C. Black> ;Cancer. 2006 Nov 1
• 42 citations
  The reliability of fine-needle aspiration biopsy as the initial diagnostic procedure for palpable masses: a 4-year experience of 730 patients from a community hospital...
  Barbara D. Florentine, Barry Staymates, Munif Rabadi, John Barstis, Alexander C. Black> ;Cancer. 2006 Jul 15
• 19 citations
  Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomiz...
  Suresh Ramalingam, John Barstis, Michael C. Perry, Renato V. La Rocca, Sreenivasa Nattam, David Rinaldi, Ray Clark, Glenn Mills, Chandra P. Belani> ;Journal of Thoracic Oncology. 2006 Mar 1
• 3 citations
  Myelopathy After Radiation Therapy and Chemotherapy with Capecitabine and Gemcitabine
  John Barstis, Alexander C. Black> ;Cancer Investigation. 2005 Jan 1
• 150 citations
  Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Obse...
  Chandra P. Belani, John Barstis, Michael C. Perry, Renato V. La Rocca, Sreenivasa Nattam, David Rinaldi, Ray Clark, Glenn Mills> ;Journal of Clinical Oncology. 2003 Aug 1
• 9 citations
  Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.
  Christos Emmanouilides, Peter Rosen, Milhan Telatar, R. Malone, Linda D. Bosserman, Harry Menco, Ravi Patel, John Barstis, Wayne W. Grody> ;Clinical Lymphoma. 2000 Sep 1
• Increased inactive creatine kinase B protein in the plasma of patients with malignancy.
  Burnam, M. H., Barstis, J. L., Stern, C. S., Rose, D. M., Crouch, M. A., Haskell, C. M., Singh, B. N.> ;Clin Chem. 1981 Oct
• Join now to see all